Compare
Pennant Group, Inc. vs InnovAge Holding Corp. vs U S Physical Therapy Inc vs LifeStance Health Group, Inc.
| Latest fiscal year | Pennant Group, Inc. PNTG | InnovAge Holding Corp. INNV | U S Physical Therapy Inc USPH | LifeStance Health Group, Inc. LFST |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-06-30 | 2025-12-31 | 2025-12-31 |
| Revenue | $947.71M | $989.71M | $780.99M | $1.42B |
| Revenue growth (YoY) | +36.3% | +15.9% | +16.3% | +13.9% |
| Gross margin | n/a | 23.0% | 19.2% | n/a |
| Operating margin | 5.5% | 0.3% | 11.1% | 1.7% |
| Net margin | 3.1% | -0.3% | 5.1% | 0.7% |
| Net income | $29.58M | -$2.54M | $39.58M | $9.66M |
| EPS (Diluted) | $0.84 | -$0.02 | $1.42 | n/a |
| Operating cash flow | $48.29M | $64.71M | $75.06M | $146.15M |
| Free cash flow | $36.26M | $50.41M | $60.99M | $110.03M |
| Cash & equivalents | n/a | $97.89M | $35.57M | $248.64M |
| Total assets | $968.18M | $557.39M | $1.20B | $2.20B |
| Total liabilities | $593.93M | $288.62M | $433.81M | $682.92M |
| Shareholders' equity | $374.25M | $235.60M | $476.89M | $1.52B |
| Return on year-end equity | 7.9% | -1.1% | 8.3% | 0.6% |
| Shares outstanding | 34.63M | 136.02M | n/a | 388.32M |
Revenue, most recent five fiscal years
| Fiscal year | Pennant Group, Inc. | InnovAge Holding Corp. | U S Physical Therapy Inc | LifeStance Health Group, Inc. |
|---|---|---|---|---|
| Latest | $947.71M Ended 2025-12-31 | $989.71M Ended 2026-06-30 | $780.99M Ended 2025-12-31 | $1.42B Ended 2025-12-31 |
| 1 year earlier | $695.24M Ended 2024-12-31 | $853.70M Ended 2025-06-30 | $671.35M Ended 2024-12-31 | $1.25B Ended 2024-12-31 |
| 2 years earlier | $544.89M Ended 2023-12-31 | $763.86M Ended 2024-06-30 | $604.80M Ended 2023-12-31 | $1.06B Ended 2023-12-31 |
| 3 years earlier | $473.24M Ended 2022-12-31 | $688.09M Ended 2023-06-30 | $553.14M Ended 2022-12-31 | $859.54M Ended 2022-12-31 |
| 4 years earlier | $439.69M Ended 2021-12-31 | $698.64M Ended 2022-06-30 | $495.02M Ended 2021-12-31 | $667.51M Ended 2021-12-31 |